News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Covidien Ltd Results Top Forecasts; Shares Rise
January 26, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO, Jan 26 (Reuters) - Medical products maker Covidien Ltd (COV.N) on Monday reported quarterly earnings, excluding special items, that exceeded analyst expectations, helped by higher sales of a generic version of painkiller OxyContin.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Tariffs
Most Life Sciences Companies Not Planning New Investments After Tariffs: Report
October 7, 2025
·
3 min read
·
Dan Samorodnitsky
Layoff Tracker
Pharming’s Restructuring Triggers 20% Workforce Reduction
October 7, 2025
·
216 min read
·
BioSpace Editorial Staff
Business
BioSpace
Honors 40 Under 40 Winners Whose Impact Reflects Industry’s Grit
October 7, 2025
·
2 min read
·
Angela Gabriel
Artificial intelligence
AstraZeneca Makes Another AI Deal With $555M Algen Alliance
October 6, 2025
·
2 min read
·
Tristan Manalac
